SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001628280-18-003637
Filing Date
2018-03-28
Accepted
2018-03-28 07:24:52
Documents
9
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 6-K q4-2017x6k.htm 6-K 19776
2 EXHIBIT 99.1 q4-2017exhibit991pr.htm EX-99.1 195704
3 EXHIBIT 99.2 q4-2017xex992fsxannual.htm EX-99.2 1750943
4 EXHIBIT 99.3 q4-2017xex993mdaxannual.htm EX-99.3 554299
5 aeternazentarislogoa65.jpg GRAPHIC 14913
6 aeternazentarislogoa67.jpg GRAPHIC 14913
7 aeternazentarislogoa71.jpg GRAPHIC 14913
8 aeternazentarislogoa75.jpg GRAPHIC 14150
9 outsource.jpg GRAPHIC 57978
  Complete submission text file 0001628280-18-003637.txt   2683458
Mailing Address C/O STIKEMAN ELLIOTT LLP 1155 RENE-LEVESQUE BLVD. WEST, 41ST FLR MONTREAL A8 H3B 3V2
Business Address C/O STIKEMAN ELLIOTT LLP 1155 RENE-LEVESQUE BLVD. WEST, 41ST FLR MONTREAL A8 H3B 3V2 843-900-3201
Aeterna Zentaris Inc. (Filer) CIK: 0001113423 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38064 | Film No.: 18717021
SIC: 2834 Pharmaceutical Preparations